Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone in chronic neuropathic pain
NCT01205516Phase 4Terminated
- Sponsor
- Nova Scotia Health
- Start
- Jan 2013
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methadone in chronic neuropathic pain, sponsored by Nova Scotia Health. Primary endpoint: Pain intensity level at 16 weeks. Started Jan 2013; status: terminated.
02
Drugs
methadone
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT01205516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205516.